Thursday, November 1, 2018

Carotid artery wall thickness measured by MRI better in predicting CVC than Ultrasound

A study by Zhang et al published in Radiology found magnetic resonance imaging (MRI) wall thickness measurements of carotid arteries enhances the quality of cardiovascular disease (CVC) risk assessment. 

The researchers enrolled 698 patients from the Multi-Ethnic Study of Atherosclerosis (MESA) from July 2000 to December 2013. Their average age was 63 years old and had no known history of cardiovascular disease. Patients underwent ultrasound and MRI between 2000 and 2004 to compare carotid artery wall thickness. 

The researchers found the association between wall thickness and cardiovascular events was stronger with contrast and non-contrast-enhanced MRI than it was for the ultrasound-based carotid intima-media thickness test. When included in the same model, MRI wall thickness, but not intima-media thickness, remained associated with the outcomes.

Monday, October 1, 2018

Breast MRI Improves depiction of DCIS Components

A study by Kuhl et al published in Radiology found magnetic resonance imaging (MRI) of the breast improves depiction of ductal carcinoma in situ (DCIS) components of invasive breast cancers prior to surgery.

The authors performed a prospective two-center study of 593 patients with biopsy proven invasive breast cancer that underwent breast MRI in addition to conventional imaging. 

The outcomes showed surgical-pathologic evaluation demonstrated DCIS components in 139 (23%) women. MRI had significantly higher sensitivity in the diagnosis of DCIS components pre-operatively in (84%; 118 women out of 139) than that of conventional imaging, which detected (36%; 51 of the 139 women). More than 50 percent of DCIS components were detected with MRI alone. 

The researchers also found the sensitivity benefits of MR imaging over conventional imaging improved with increasing relative size, and with increasing nuclear grade of DCIS components. Positive margin rates were generally low and did not diverge significantly between the 139 women with DCIS components versus the 454 women who lacked them.

The authors concluded that breast MRI improves depiction of DCIS components of invasive breast cancers before surgery.

Saturday, September 1, 2018

Breast MRI Without Contrast Detects Cancer.

According to a study published in Radiology a radiomics technique that is based on diffusion weighted imaging with an adapted kurtosis model reduces false-positive results in both malignant and benign breast lesions when compared with x-ray mammography.

This institutional study included 222 women at two study sites (site 1: training set of 95 patients; mean age of 58.6 years; with 61 malignant and 34 benign lesions; and site 2: independent set of 127 patients; mean age, 58.2 years with 61 malignant with 66 benign lesions). 

Among all 222 patients, histopathology results confirmed malignant lesions in 122 women (55%); invasive ductal carcinoma was the most common finding, in 90 patients (74%). Benign lesions were found in the remaining 100 women (45%); fibrosis (21 patients, 21%) and fibroadenoma (20 patients, 20%) were the most common abnormalities.

All women presented with findings suspicious for cancer at x-ray mammography (BI-RADS 4 or 5) and an indication for biopsy. Before biopsy, diffusion-weighted MR imaging (b values, 0–1500 sec/mm2) was performed by using 1.5-T imagers from different MR imaging vendors. Lesions were segmented and voxel-based kurtosis fitting adapted to account for fat signal contamination was performed. Conventional interpretations of MR imaging were also assessed for comparison.
The kurtosis radiomics model reduced false-positive results from 66 to 20 (specificity 70.0% [46 of 66]) at the predefined sensitivity of greater than 98.0% [60 of 61] in the independent test set, with BI-RADS 4a and 4b lesions benefiting from the analysis (specificity 74.0%, [37 of 50]; 60.0% [nine of 15]) and BI-RADS 5 lesions showing no added benefit. The model significantly improved specificity compared with the median apparent diffusion coefficient (P < .001) and apparent kurtosis coefficient (P = .02) alone. Conventional reading of dynamic contrast material–enhanced MR imaging provided sensitivity of 91.8% (56 of 61) and a specificity of 74.2% (49 of 66). Accounting for fat signal intensity during fitting significantly improved the area under the curve of the model (P = .001).

 The authors concluded the radiomics model based on kurtosis diffusion-weighted imaging allowed for reliable differentiation between malignant and benign breast lesions.

Wednesday, August 1, 2018

Rotational Angiography in the study of Congenital Cardiac Anomalies in Children

A study by Parini et al published in Pediatric Cardiology. reports on the use of Rotational angiography (RA) for evaluating congenital heart disease (CHD) in the cardiac cath lab, permits acquisition of 3D datasets with superior spatial resolution.  The authors describe five cases on whom they created 3D-printed hearts in patients with CHD.

Diagnoses included coronary artery aneurysm, Glenn shunt, coarctation of the aorta, tetralogy of Fallot with major aortopulmonary collateral arteries (MAPCAs), and pulmonary artery stenosis. There was no significant measurement difference between RA and the printed model (r = 0.990, p < 0.01). There was also no significant inter-observer variability. 

The authors concluded that RA could generate highly accurate 3D models in congenital heart disease.  These models can be useful in patient evaluation and management.

Sunday, July 1, 2018

Abbreviated Prostatic MRI

Kuhl et published in Radiology findings of their study in which they explored the accuracy of an abbreviated MRI of the prostate.  Multi-parametric contrast-enhanced MR imaging was performed in men with elevated PSA who after negative transrectal US-guided biopsy underwent state-of-the-art, full multiparametric contrast-enhanced MR imaging at 3.0-T that included high-spatial-resolution structural imaging in several planes, diffusion-weighted imaging at 0, 800, 1000, and 1400 mm2/sec, and dynamic contrast-enhanced MR imaging, obtained without endorectal coil within 34 minutes 19 seconds.

One of four radiologists first reviewed only two sequences of the study
 consisting of single-plane (axial) structural imaging (T2-weighted turbo spin-echo and diffusion-weighted imaging), acquired within 8 minutes 45 seconds (referred to as bi-parametric MR imaging), and established a diagnosis; only thereafter, the remaining full multiparametric contrast-enhanced MR images were read. Men with PI-RADS categories 3–5 underwent MR-guided targeted biopsy. Men with PI-RADS categories 1–2 remained in urologic follow-up for at least 2 years, with rebiopsy (transrectal US-guided or transperineal) when appropriate. 

A total of 542 men, aged 65 years with median PSA of 7 ng/mL, were included. Bi-parametric MR imaging helped detect clinically significant prostate cancer in 138 men. Full multi-parametric contrast-enhanced MR imaging allowed detection of one additional clinically significant prostate cancer (a stage pT2a, intermediate-risk cancer with a Gleason score of 3+4) and caused 11 additional false-positive diagnoses. Diagnostic accuracy for detection of clinically significant cancer of bi-parametric MR imaging was 89.1% (483 of 542) was similar to that of full multi-parametric contrast-enhanced MR imaging 87.2% (473 of 542). 
The authors concluded that bi-parametric MR imaging which can be done with two sequences and without contrast injection in less that 9 minutes allows for detection of clinically significant prostate cancer with a rate equivalent to conventional full multi-parametric contrast-enhanced MR imaging protocols.

Friday, June 1, 2018

CT Angiography is Accurate in Diagnosis of Small Cerebral Aneurysms

A study published by Yang et al in Radiology assessed the accuracy of computed tomographic (CT) angiography for diagnosis of cerebral aneurysms 5 mm or smaller.

A total of 1366 patients who underwent cerebral CT angiography followed by DSA were included in the study.

Of 1366 patients in their study, 579 patients had 711 small aneurysms at DSA. By using DSA as the reference standard, the respective sensitivity, specificity, and accuracy of CT angiography was analyzed for two readers.  The sensitivity of CT angiography was lower for detection of aneurysms smaller than 3 mm that had not ruptured compared with aneurysms that were 3–5 mm and had ruptured (P < .001). No difference existed for the sensitivities of CT angiography for diagnosis of aneurysms in the anterior versus posterior circulation (P > .0167). Excellent or good inter-reader agreement was found for detection of intracranial aneurysms on a per-patient (κ = 0.982) and per-aneurysm (κ = 0.748) basis.

The authors concluded that CT angiography has high accuracy for detection of small cerebral aneurysms.

Tuesday, May 1, 2018

Radiation Segmentectomy (RS) in Hepatocellular Carcinoma

Research by Lewandowski et al published in Radiology suggests that patients with small hepatocellular carcinomas (HCC) respond favorably to intra-arterial treatment with yttrium-90.

The authors reported outcomes from a retrospective analysis of 70 patients with HCC that were less or equal to 5 cm.  The patients received a radiation dose of more than 190 Gy.

Sixty-three patients (90%) showed response by using European Association for the Study of the Liver  (EASL) criteria, of which 41 (59%) showed complete response. Fifty patients (71%) achieved response by using World Health Organization (WHO) criteria, of which 11 (16%) achieved complete response. Response rates at 6 months were 86% and 49% by using EASL and WHO criteria, respectively. Median overall survival was 6.7 years; survival probability at 1, 3, and 5 years was 98%, 66%, and 57%, respectively. Overall survival probability at 1, 3, and 5 years was 100%, 82%, and 75%, respectively, in patients with baseline tumor size less than or equal to 3 cm (n = 45) and was significantly longer than in patients with tumors greater than 3 cm (P = .026).

The authors concluded that RS provides tumor control, and survival outcomes comparable to curative-intent treatments for patients with early-stage HCC who have preserved liver function.